AVALO THERAPEUTICS, INC. Increase (Decrease) in Deferred Income Taxes
AVALO THERAPEUTICS, INC. (AVTX) reported Increase (Decrease) in Deferred Income Taxes of -$28.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2023-03-29
- AVALO THERAPEUTICS, INC. increase (decrease) in deferred income taxes for fiscal 2022 was -$28.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in deferred income taxes for fiscal 2021 was -$22.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in deferred income taxes for fiscal 2020 was -$197.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in deferred income taxes for fiscal 2019 was -$16.74K.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$28.00K 10-K · filed 2023-03-29 | |
| 2021-12-31 | -$22.00K 10-K · filed 2023-03-29 | |
| 2020-12-31 | -$197.00K 10-K · filed 2022-03-02 | -$195.59K 10-K · filed 2021-03-08 |
| 2019-12-31 | -$16.74K 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |